Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors
January 7th, 2019
8.4K views
Here, we demonstrate the methods for in vivo quantification of leukocyte egress from naïve, inflamed, and malignant murine skin. We perform a head-to-head comparison of two models: transdermal FITC application and in situ photoconversion. Furthermore, we demonstrate the utility of photoconversion for tracking leukocyte egress from cutaneous tumors.
Overview
This study investigates the in vivo quantification of leukocyte egress from various skin conditions, including naive, inflamed, and malignant murine skin. The authors compare two photoconversion techniques to track leukocyte movement and examine their utility in understanding immune dynamics in cutaneous tumors.
Key Study Components
Research Area
- Immunology
- Cancer biology
- Leukocyte dynamics
Background
- Leukocyte egress is crucial in inflammation and cancer.
- Understanding leukocyte behavior can provide insights into disease progression.
- Existing techniques may not effectively quantify endogenous immune cell populations.
Methods Used
- In vivo photoconversion techniques for leukocyte tracking.
- Use of Kaede transgenic mice.
- Flow cytometry for analysis of leukocyte populations.
Main Results
- Photoconversion efficiently tracked leukocyte egress from tumors.
- Increased leukocyte infiltration was observed following violet light exposure.
- Photoconversion efficiency varied significantly with tumor type and size.
Conclusions
- This study establishes effective methodologies for quantifying leukocyte behavior in vivo.
- Findings enhance understanding of immune responses in skin inflammation and cancer.
Frequently Asked Questions
What is photoconversion?
Photoconversion is a technique that allows tracking of specific leukocyte populations by converting fluorescent proteins in vivo using light exposure.
Why focus on leukocyte egress?
Leukocyte egress is crucial for studying immune responses during inflammation and tumor progression.
What models were compared in the study?
The study compared transdermal FITC application and in situ photoconversion methods.
What organism was used in the experiments?
Kaede transgenic mice were used as the biological model for this study.
How was leukocyte infiltration measured?
Leukocyte infiltration was quantified using flow cytometry of the harvested tissues post-photoconversion.
What implications do the study findings have?
The findings have implications for understanding immune cell dynamics in disease, which can inform therapeutic strategies.
Can these methods be used for other tissues?
Yes, the techniques can potentially be applied to other tissue types, contingent on the ability to administer light for photoconversion.
Executive Industry Relevance
Quantifying leukocyte egress from peripheral tissues provides critical mechanistic insight into immune surveillance and tumor microenvironment dynamics. The described photoconversion method enables direct tracking of endogenous leukocyte populations, supporting target validation and predictive confidence in immuno-oncology discovery. This approach addresses a key gap in understanding context-dependent leukocyte behavior, informing risk-adjusted decisions in early immunotherapy development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of leukocyte residence and exit dynamics to clarify mechanistic hypotheses in tumor immune microenvironments.
- Operational Value: Quantifies endogenous immune cell populations without adoptive transfer, reducing experimental variability.
- Predictive Value: Supports biological de-risking by revealing context-dependent egress kinetics that influence therapeutic response.
Screening & Assay Development
- Assay Readiness: Generates quantitative, flow-cytometry-compatible readouts of leukocyte conversion and egress for standardized screening.
- Reproducibility: Provides consistent photoconversion efficiency metrics across tissue types, supporting assay validation.
- Scalability: Adaptable to multiple tissue sites (skin, tumors, lymph nodes) using light-dependent activation, enabling platform reuse.
Translational & Preclinical Research
- Disease Relevance: Models leukocyte dynamics in cutaneous tumors and inflamed skin, aligning with preclinical immuno-oncology studies.
- Translational Continuity: Links discovery-phase egress measurements to preclinical validation of immune cell trafficking.
- Mechanistic De-risking: Clarifies how tumor-associated factors like melanin and size affect leukocyte tracking, informing model selection.
Pipeline & Workflow Integration
The method fits within the discovery-to-preclinical continuum by enabling quantitative immune monitoring that informs lead identification and preclinical advancement decisions.
- Discovery Biology: Supports hypothesis testing of leukocyte trafficking pathways and functional validation of immunomodulatory targets.
- Screening: Delivers quantitative egress measurements that allow comparison of immune responses across experimental conditions.
- Analytics: Generates flow-cytometry-based conversion efficiency and leukocyte counts as decision-grade readouts.
- Translational Research: Connects intraluminal leukocyte egress to lymph node immune output, supporting biomarker-aligned preclinical studies.
- Enterprise Reuse: Establishes a reusable photoconversion platform applicable across tumor models and inflammatory conditions.
Operational & Enterprise Impact
- Scientific Value: Provides predictive confidence in leukocyte behavior models, reducing mechanistic ambiguity in immuno-oncology.
- Operational Value: Standardizes leukocyte tracking via photoconversion, enhancing reproducibility across labs and studies.
- Strategic Value: Improves go/no-go decisions by quantifying immune cell dynamics that correlate with therapeutic efficacy.
- Portfolio Impact: Enables risk-adjusted prioritization of immunomodulatory candidates based on validated egress kinetics.
Implementation Considerations
- Requires expertise in photoconversion techniques, flow cytometry, and transgenic mouse handling.
- Dependent on 405 nm light source availability and tissue accessibility for optimal light delivery.
- Necessitates standardization of exposure time and power across tumor types to account for melanin and size effects.
- Requires validation of leukocyte subset specificity to avoid confounding signals from non-target cells.
- Limited by tissue opacity and pigmentation, which can reduce photoconversion efficiency in deeply pigmented or large tumors.
Biopharma FAQs
Why does quantifying leukocyte egress matter for target validation in immuno-oncology?
Quantifying leukocyte egress enables direct measurement of endogenous immune cell trafficking from tumors, providing mechanistic insight into target engagement and immune response dynamics. This supports target validation by clarifying how immunomodulatory agents influence leukocyte residence and exit kinetics in the tumor microenvironment.
How does isolating the photoconversion variable enable mechanistic discovery in leukocyte tracking?
Photoconversion isolates the variable of endogenous leukocyte labeling by using light-dependent conversion of Kaede protein, avoiding confounding signals from transferred cells. This allows researchers to attribute observed egress specifically to photoconverted populations, enabling clear mechanistic interpretation of immune dynamics.
What quantitative measurements does leukocyte photoconversion enable for pipeline decision-making?
Leukocyte photoconversion enables quantitative measurement of conversion efficiency and egress kinetics via flow cytometry, including CD45+ cell tracking from tissue to draining lymph nodes. These measurements provide decision-grade data on immune cell dynamics that inform lead selection and preclinical advancement.
Why are replication requirements important for leukocyte egress studies in cross-functional collaboration?
Replication ensures consistent photoconversion efficiency and leukocyte tracking across experiments, which is essential for reliable data sharing between discovery, preclinical, and translational teams. Standardized replication supports assay robustness and confidence in comparative studies across tumor models.
What statistical analysis capabilities are required before implementing leukocyte photoconversion in discovery workflows?
Implementation requires statistical analysis of conversion efficiency, leukocyte infiltration changes, and egress rates using flow cytometry data, including comparison of pre- and post-conversion samples. These analyses enable quantification of significant differences in leukocyte behavior across experimental conditions, supporting data-driven decisions.
Chapters in this video
0:04
Title
0:46
Mouse Pinna Inflammation Induction, Vaccinia Infection, Photoconversion, and Tissue Processing
2:52
Intradermal Melanoma Tumor Photoconversion and Tissue Processing
4:00
Flow Cytometry Preparation & Analysis
5:18
Results: Representative Photoconversion Efficiency in Skin and the Tumor Microenvironments
7:55
Conclusion
